Article Information
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Received September 15, 2016
- Revision received December 30, 2016
- Accepted February 1, 2017
- Originally published March 14, 2017.
Article Versions
- You are currently viewing an Previous Version of this article (March 14, 2017).
- View the most recent version of this article
Copyright & Usage:
© 2017 American Heart Association, Inc.
Author Information
- Mònica Millán, MD, PhD,
- Sebastià Remollo, MD,
- Helena Quesada, MD,
- Arturo Renú, MD,
- Alejandro Tomasello, MD,
- Priyanka Minhas, MD,
- Natalia Pérez de la Ossa, MD, PhD,
- Marta Rubiera, MD, PhD,
- Laura Llull, MD, PhD,
- Pedro Cardona, MD,
- Fahad Al-Ajlan, MD,
- María Hernández, MD,
- Zarina Assis, MD,
- Andrew M. Demchuk, MD,
- Tudor Jovin, MD,
- Antoni Dávalos, MD, PhD,
- on behalf of the REVASCAT Trial Investigators
- From the Stroke Unit and Interventional Neuroradiology Section, Department of Neurosciences, Hospital Germans Trias, Universitat Autònoma de Barcelona, Spain (M.M., S.R., N.P.d.l.O., M.H., A.D.); Stroke Unit, Neurology Department, Hospital de Bellvitge, L’Hospitalet de Llobregat (Barcelona), Spain (H.Q., P.C.); Stroke Unit, Neurology Department, Hospital Clínic, Barcelona, Spain (A.R., L.L.); Radiology Department (A.T.) and Stroke Unit, Neurology Department (M.R.), Hospital Vall d’Hebron, Barcelona, Spain; Calgary Stroke Program, Hotchkiss Brain Institute, Department of Clinical Neurosciences and Radiology, University of Calgary (P.M., F.A.-A., Z.A., A.M.D.); and Stroke Institute, Department of Neurology, University of Pittsburgh Medical Center, PA (T.J.).
- Correspondence to Mònica Millán, MD, PhD, Stroke Unit, Neurosciences Department, Hospital Germans Trias i Pujol, Carretera de Canyet s/n, Badalona 08916 (Barcelona), Spain. E-mail mmillan.germanstrias{at}gencat.cat
Statistics from Altmetric.com
Article usage
Jump to
Current Issue
Article Tools
Share this Article
- Vessel Patency at 24 Hours and Its Relationship With Clinical Outcomes and Infarct Volume in REVASCAT Trial (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior Circulation Large Vessel Occlusion Presenting Within Eight Hours of Symptom Onset)Permalink:
